Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene-based therapeutic angiogenesis.

Jennifer L Yeh1, Frank J Giordano

  • 1Department of Medicine, Cardiovascular Gene Therapy Program, Yale University School of Medicine, New Haven, CT, USA.

Seminars in Thoracic and Cardiovascular Surgery
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Cardiovascular drugs and therapy·2021
Same author

Generation of a hypoxia-sensing mouse model.

Genesis (New York, N.Y. : 2000)·2019
Same author

Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress.

Pflugers Archiv : European journal of physiology·2017
Same author

Endothelial HIF-1α Enables Hypothalamic Glucose Uptake to Drive POMC Neurons.

Diabetes·2017
Same author

Low-dose dasatinib rescues cardiac function in Noonan syndrome.

JCI insight·2016
Same author

A Remote Role for Renalase.

EBioMedicine·2016
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Gene therapy offers a promising approach to stimulate new blood vessel growth for vascular disease by ensuring continuous exposure to angiogenic proteins. This evolving field shows potential but requires further research into complex regulatory factors.

Area of Science:

  • Cardiovascular research
  • Regenerative medicine
  • Molecular biology

Background:

  • Advanced vascular disease often necessitates strategies to promote new blood vessel growth (angiogenesis).
  • Angiogenic proteins are key to stimulating neovascularization but typically have short serum half-lives.
  • Gene therapy presents a method to achieve sustained expression of angiogenic proteins for prolonged therapeutic effects.

Purpose of the Study:

  • To review the current status of angiogenic gene therapy for vascular disease.
  • To compare gene therapy with direct angiogenic protein delivery.
  • To discuss clinical trial outcomes and future directions in therapeutic angiogenesis.

Main Methods:

  • Review of existing literature on angiogenic gene therapy.

Related Experiment Videos

  • Analysis of early and recent clinical trial data.
  • Comparison of gene therapy mechanisms with protein delivery systems.

    • Main Results:

    • Early clinical trials suggest angiogenic gene therapy can be effective.
    • Gene therapy overcomes the short half-life limitation of angiogenic proteins.
    • The field is dynamic, with ongoing research into the complex regulation of angiogenesis.

    Conclusions:

    • Angiogenic gene therapy is a developing strategy for treating ischemic conditions.
    • Further understanding of angiogenesis regulation will refine therapeutic approaches.
    • Continued research is essential to optimize gene therapy for vascular disease.